Randomized Trialhigh evidence

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

The New England journal of medicine·November 12, 2026·PMID 43013818

Why it matters

Venous thromboembolism prophylaxis after joint replacement remains a common clinical decision. This large trial provides direct comparative data showing that aspirin, despite its convenience and lower cost, does not meet noninferiority for preventing death or symptomatic VTE compared with warfarin or rivaroxaban.

Infographic summary of Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled